MX2010004366A - Materiales inmiscibles en agua como vehiculos para suministro de farmacos. - Google Patents
Materiales inmiscibles en agua como vehiculos para suministro de farmacos.Info
- Publication number
- MX2010004366A MX2010004366A MX2010004366A MX2010004366A MX2010004366A MX 2010004366 A MX2010004366 A MX 2010004366A MX 2010004366 A MX2010004366 A MX 2010004366A MX 2010004366 A MX2010004366 A MX 2010004366A MX 2010004366 A MX2010004366 A MX 2010004366A
- Authority
- MX
- Mexico
- Prior art keywords
- water
- vehicles
- drug delivery
- immiscible materials
- immiscible
- Prior art date
Links
- 239000000463 material Substances 0.000 title abstract 3
- 238000012377 drug delivery Methods 0.000 title 1
- 239000005426 pharmaceutical component Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Abstract
Se describe una composición farmacéutica que incluye al menos un componente farmacéutico y por lo menos un material inmiscible en agua. El componente farmacéutico es más soluble en el material inmiscible en agua que en agua. La composición farmacéutica es adecuada para administración ocular.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98530807P | 2007-11-05 | 2007-11-05 | |
PCT/US2008/080665 WO2009061607A2 (en) | 2007-11-05 | 2008-10-22 | Water-immiscible materials as vehicles for drug delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010004366A true MX2010004366A (es) | 2010-05-05 |
Family
ID=40185076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010004366A MX2010004366A (es) | 2007-11-05 | 2008-10-22 | Materiales inmiscibles en agua como vehiculos para suministro de farmacos. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20100286121A1 (es) |
EP (1) | EP2214644B1 (es) |
JP (1) | JP2011502990A (es) |
KR (1) | KR20100067684A (es) |
CN (1) | CN101848701A (es) |
AU (1) | AU2008325036B2 (es) |
BR (1) | BRPI0819175A2 (es) |
CA (1) | CA2703000C (es) |
ES (1) | ES2402321T3 (es) |
HK (1) | HK1144073A1 (es) |
MX (1) | MX2010004366A (es) |
SG (1) | SG185955A1 (es) |
WO (1) | WO2009061607A2 (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2391419T3 (pl) | 2009-01-29 | 2019-12-31 | Forsight Vision4, Inc. | Dostarczanie leku do tylnego odcinka |
US8623395B2 (en) | 2010-01-29 | 2014-01-07 | Forsight Vision4, Inc. | Implantable therapeutic device |
EP2394636B1 (en) * | 2010-05-28 | 2014-03-19 | Novagali Pharma S.A. | Method for treating retinal conditions using an intraocular tamponade |
US10166142B2 (en) | 2010-01-29 | 2019-01-01 | Forsight Vision4, Inc. | Small molecule delivery with implantable therapeutic device |
WO2012019136A2 (en) | 2010-08-05 | 2012-02-09 | Forsight Vision 4, Inc. | Injector apparatus and method for drug delivery |
CA2807537C (en) | 2010-08-05 | 2018-09-18 | Forsight Vision4, Inc. | Combined drug delivery methods and apparatus |
EP3960134A1 (en) | 2010-08-05 | 2022-03-02 | ForSight Vision4, Inc. | Implantable therapeutic device |
CA2818612C (en) | 2010-11-19 | 2020-12-29 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
EP2726016B1 (en) | 2011-06-28 | 2023-07-19 | ForSight Vision4, Inc. | An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye |
PT2755600T (pt) | 2011-09-16 | 2021-04-19 | Forsight Vision4 Inc | Aparelhos de troca de fluidos |
US10010448B2 (en) | 2012-02-03 | 2018-07-03 | Forsight Vision4, Inc. | Insertion and removal methods and apparatus for therapeutic devices |
US9056057B2 (en) | 2012-05-03 | 2015-06-16 | Kala Pharmaceuticals, Inc. | Nanocrystals, compositions, and methods that aid particle transport in mucus |
KR102154880B1 (ko) | 2012-05-03 | 2020-09-10 | 칼라 파마슈티컬스, 인크. | 개선된 점막 수송을 나타내는 제약 나노입자 |
US11596599B2 (en) | 2012-05-03 | 2023-03-07 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
US9827191B2 (en) | 2012-05-03 | 2017-11-28 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
US9968603B2 (en) | 2013-03-14 | 2018-05-15 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
US9526654B2 (en) | 2013-03-28 | 2016-12-27 | Forsight Vision4, Inc. | Ophthalmic implant for delivering therapeutic substances |
BR112016022394A2 (pt) * | 2014-03-27 | 2017-08-15 | Servicio Andaluz De Salud | Composição farmaceuticamente aceitável, composição na forma de uma solução injetável farmaceuticamente aceitável, uso da composição, e, método para a preparação da composição injetável farmaceuticamente aceitável |
EP3679908A1 (en) | 2014-07-15 | 2020-07-15 | ForSight Vision4, Inc. | Ocular implant delivery device |
CN107106551A (zh) | 2014-08-08 | 2017-08-29 | 弗赛特影像4股份有限公司 | 受体酪氨酸激酶抑制剂的稳定且可溶的制剂和其制备方法 |
AU2015346450B2 (en) | 2014-11-10 | 2020-01-30 | Forsight Vision4, Inc. | Expandable drug delivery devices and method of use |
US11324800B2 (en) | 2015-01-15 | 2022-05-10 | Wellspring Ophthalmics, Inc. | Aqueous suspensions of cyclosporin |
US20200237859A1 (en) | 2019-01-25 | 2020-07-30 | Newport Research, Inc. | Aqueous suspensions of cyclosporin |
JP2018510872A (ja) * | 2015-03-23 | 2018-04-19 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 高濃度かつ/または高粘度の活性薬剤溶液を注射するための方法および組成物 |
CN113069681B (zh) | 2015-11-20 | 2022-12-23 | 弗赛特影像4股份有限公司 | 制造用于缓释药物递送的治疗装置的方法 |
US20170196802A1 (en) | 2016-01-08 | 2017-07-13 | Abon Pharmaceuticals, Llc | Long Acting Injectable Formulations |
MX2018012021A (es) | 2016-04-05 | 2019-01-24 | Forsight Vision4 Inc | Dispositivos de administracion de farmacos oculares implantables. |
PT3266446T (pt) * | 2016-07-07 | 2019-01-30 | Salvat Lab Sa | Composição oftálmica compreendendo óleo de rícino e triglicérido de cadeia média |
CN115607358A (zh) | 2017-11-21 | 2023-01-17 | 弗赛特影像4股份有限公司 | 用于可扩展端口递送系统的流体交换装置及使用方法 |
MX2020011535A (es) * | 2018-05-01 | 2020-11-24 | Chibi Inc | Formulacion de gotas para ojos y metodos para la liberacion sostenida de medicamento a la retina. |
CN109091675B (zh) * | 2018-08-31 | 2021-09-17 | 杭州赫尔斯科技有限公司 | 一种复方低浓度阿托品类药物滴眼液及其制备方法 |
CN113749092A (zh) * | 2020-06-03 | 2021-12-07 | 迈克斯(如东)化工有限公司 | 不饱和脂肪酸酯化物应用、农化组合物和低眼刺农药制剂及其应用 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3767788A (en) * | 1970-06-08 | 1973-10-23 | Burton Parsons Chemicals Inc | Ophthalmic solution |
FR2638089A1 (fr) * | 1988-10-26 | 1990-04-27 | Sandoz Sa | Nouvelles compositions ophtalmiques a base d'une cyclosporine |
JP2613139B2 (ja) * | 1990-07-19 | 1997-05-21 | エスエス製薬 株式会社 | キノロンカルボン酸誘導体 |
US5518731A (en) * | 1990-09-27 | 1996-05-21 | Allergan, Inc. | Nonaqueous fluorinated drug delivery vehicle suspensions |
US5912015A (en) * | 1992-03-12 | 1999-06-15 | Alkermes Controlled Therapeutics, Inc. | Modulated release from biocompatible polymers |
US5384333A (en) * | 1992-03-17 | 1995-01-24 | University Of Miami | Biodegradable injectable drug delivery polymer |
US5830508A (en) * | 1992-08-06 | 1998-11-03 | Deo Corporation | Composition for treating dry eye |
US5366739A (en) * | 1992-08-06 | 1994-11-22 | Deo Corporation | Method of ophthalmic drug delivery |
EP0656779B1 (en) * | 1992-08-28 | 2000-04-12 | Pharmos Corporation | Submicron emulsions as ocular drug delivery vehicles |
US5336487A (en) * | 1993-03-05 | 1994-08-09 | Refojo Miguel F | Method of treating eye disorders with silicon/fluorosilicone copolymer oil |
US5480914A (en) * | 1994-05-06 | 1996-01-02 | Allergan, Inc. | Nonaqueous thixotropic drug delivery suspensions and methods of their use |
US5718922A (en) * | 1995-05-31 | 1998-02-17 | Schepens Eye Research Institute, Inc. | Intravitreal microsphere drug delivery and method of preparation |
US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
US6331311B1 (en) * | 1996-12-20 | 2001-12-18 | Alza Corporation | Injectable depot gel composition and method of preparing the composition |
EP1082966A4 (en) * | 1998-05-15 | 2004-07-21 | Wakamoto Pharma Co Ltd | ANTI-INFLAMMATORY EYE DROPS |
US6699492B2 (en) * | 1999-03-31 | 2004-03-02 | Insite Vision Incorporated | Quinolone carboxylic acid compositions and related methods of treatment |
US20030018044A1 (en) * | 2000-02-18 | 2003-01-23 | Peyman Gholam A. | Treatment of ocular disease |
AU2001261748A1 (en) * | 2000-05-19 | 2001-12-03 | Alcon Laboratories Inc. | Antibiotic compositions for treatment of the eye, ear and nose |
US6495164B1 (en) * | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
KR20030061390A (ko) * | 2000-11-01 | 2003-07-18 | 메르크 파텐트 게엠베하 | 안구 질환 치료용 조성물 및 방법 |
US7354574B2 (en) * | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US7083802B2 (en) * | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US7417056B2 (en) * | 2004-11-12 | 2008-08-26 | Schering Ag | 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents |
BRPI0606172A2 (pt) * | 2005-06-08 | 2009-06-02 | Targegen Inc | métodos e composições para o tratamento de distúrbios oculares |
JP2010500364A (ja) * | 2006-08-07 | 2010-01-07 | ボーシュ アンド ローム インコーポレイティド | 後部眼科疾患を治療、または軽減、または改善、または緩和するための組成物と方法 |
PL2056799T3 (pl) * | 2006-08-31 | 2014-01-31 | Bausch & Lomb | Kompozycje i sposoby do leczenia lub zapobiegania jaskrze lub jej rozwojowi |
PL2061444T3 (pl) * | 2006-09-11 | 2011-09-30 | Bausch & Lomb | Kompozycje i sposoby leczenia, traktowania, kontrolowania, redukowania, łagodzenia lub zapobiegania alergii |
JP2010529133A (ja) * | 2007-06-11 | 2010-08-26 | ボーシュ アンド ローム インコーポレイティド | フルオロキノロンを用いて炎症を調節するための組成物と方法 |
US20090082337A1 (en) * | 2007-09-21 | 2009-03-26 | Srini Venkastesh | Compositions Comprising Quinolone and Methods for Treating or Controlling Infections |
-
2008
- 2008-10-22 EP EP08848169A patent/EP2214644B1/en not_active Not-in-force
- 2008-10-22 KR KR1020107009886A patent/KR20100067684A/ko not_active Application Discontinuation
- 2008-10-22 ES ES08848169T patent/ES2402321T3/es active Active
- 2008-10-22 MX MX2010004366A patent/MX2010004366A/es active IP Right Grant
- 2008-10-22 SG SG2012081634A patent/SG185955A1/en unknown
- 2008-10-22 US US12/741,266 patent/US20100286121A1/en not_active Abandoned
- 2008-10-22 CA CA2703000A patent/CA2703000C/en not_active Expired - Fee Related
- 2008-10-22 WO PCT/US2008/080665 patent/WO2009061607A2/en active Application Filing
- 2008-10-22 BR BRPI0819175 patent/BRPI0819175A2/pt not_active IP Right Cessation
- 2008-10-22 AU AU2008325036A patent/AU2008325036B2/en not_active Ceased
- 2008-10-22 CN CN200880114792A patent/CN101848701A/zh active Pending
- 2008-10-22 JP JP2010532144A patent/JP2011502990A/ja active Pending
-
2010
- 2010-11-15 HK HK10110618.9A patent/HK1144073A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2703000C (en) | 2013-08-06 |
KR20100067684A (ko) | 2010-06-21 |
HK1144073A1 (en) | 2011-01-28 |
BRPI0819175A2 (pt) | 2015-05-05 |
WO2009061607A2 (en) | 2009-05-14 |
EP2214644B1 (en) | 2013-03-20 |
US20100286121A1 (en) | 2010-11-11 |
AU2008325036B2 (en) | 2011-10-20 |
EP2214644A2 (en) | 2010-08-11 |
ES2402321T3 (es) | 2013-04-30 |
AU2008325036A1 (en) | 2009-05-14 |
SG185955A1 (en) | 2012-12-28 |
JP2011502990A (ja) | 2011-01-27 |
CA2703000A1 (en) | 2009-05-14 |
CN101848701A (zh) | 2010-09-29 |
WO2009061607A3 (en) | 2009-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010004366A (es) | Materiales inmiscibles en agua como vehiculos para suministro de farmacos. | |
WO2009133352A3 (en) | Lipid composition | |
IL250674A0 (en) | A compound for administering a drug through the large intestine | |
EG25189A (en) | Improvements in and relating to drive mechanisms suitable for use in drug delivery devices. | |
EP1962906A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE ANTICREME AND AT LEAST ONE POLYMER | |
EP1817008A4 (en) | HEATED AND STABILIZED MEDICINAL PRODUCT SMALL PARTICLE COMPOSITION | |
IL184758A0 (en) | New pharmaceutical compositions useful in the transmucosal administration of drugs | |
MY142179A (en) | Multicomponent pharmaceutical dosage form | |
IL212586A (en) | Derivative 3 - (1, 3-benzoxazole-5-yl) pyrzolo [3, 4-d] pyrimidine-4-amine, a pharmaceutical preparation and the use of a drug derivative | |
IL202614A0 (en) | Intravaginal drug delivery devices for the delivery of macromolecules and water soluble drugs | |
PL2262476T3 (pl) | Dostarczanie leku do przedniego i tylnego odcinka oka z użyciem kropli do oczu | |
SG160415A1 (en) | Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative | |
WO2007127795A3 (en) | Chitosan/nanocrystalline hydroxyapatite composite microsphere-based scaffolds | |
CL2007001724A1 (es) | Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1 | |
MX2010007083A (es) | Combinacion anti-retroviral. | |
PL2120864T3 (pl) | Kompozycja do podawania składników biologicznie czynnych w okolicy narządów płciowych i odbytnicy, i jej zastosowania | |
IL201730A (en) | History 1h - Benzaimidazole – 2 – Il – Profile – Methyl – Amino – Ethyl – 5 – Aryl – Bicyclo [2.2.2] Oct – 5 – Ann – 2 – All, Pharmaceutical preparations containing them and their use in the preparation of drugs | |
IL195931A0 (en) | Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and methods for its production | |
ZA200804207B (en) | Pharmaceutical composition comprising at least one anticancer drug and at least one polymer | |
IN2012DN00311A (es) | ||
HK1087633A1 (en) | Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances | |
MXPA05010613A (es) | Formulacion parenteral de acido micofenolico, una sal o profarmaco del mismo. | |
EP1977766A4 (en) | DRUG DELIVERY MATERIAL | |
IL197732A0 (en) | Packaging system for pharmaceutical compositions for intravenous administration and kits comprising the same | |
WO2008081829A1 (ja) | 難水溶性薬物の溶解性維持用アミノアルキルメタアクリレートコポリマーe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |